Ulcers are a common complication of poorly controlled diabetes, forming as a result of skin tissue breaking down and exposing the layers underneath. They’re most common under your big toes and the balls of your feet, and they can affect your feet down to the bones.
All people with diabetes can develop foot ulcers and foot pain, but good foot care can help prevent them. Treatment for diabetic foot ulcers and foot pain varies depending on their causes. Discuss any foot pain or discomfort with your doctor to ensure it’s not a serious problem, as infected ulcers can result in amputation if neglected. The treatment includes off-loading, and it’s helpful for all forms of diabetic foot ulcers. Pressure from walking can make an infection worse and an ulcer expand.
Covid-19 Scenario analysis:
Covid-19 a global pandemic disrupts all aspects of local clinical practice. Yet, providing care for people with diabetic foot disease remains crucial: as clinicians caring for these patients, patients can play our role in the Corona-crisis, by doing everything they can to keep their diabetic foot disease free from hospital. Every hospital bed not needed by a person with diabetic foot disease (DFD), gives room for a patient suffering from Covid-19 hence the Ulcer treatment market is steady as need for treatment is essential even during the pandemic. However no in hospital treatment and shortage of medicine and staff can cause an adverse effect on the market and shift in share.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:
Drivers:
Increased incidences of Diabetes:
The foot ulcer is more common in diabetic patients as they have a delay in the formation of granulation tissue. Controlling blood sugar levels may heal the wound quickly. If the sugar level is high, some may undergo surgery to get treated with the foot ulcer and it may get worse if ignored. The size, shape, and depth of the wound also determine the severity and need to be diagnosed properly. There are more chances of getting infected with the foot ulcer so the treatment should be done carefully especially for older age people. Chronic wounds have created a significant socioeconomic impact. Chronic wounds generally take longer to heal and require advanced wound care therapies. Diabetic ulcers are becoming more common due to increase in incidence of both type I and maturity-onset diabetes in developed countries across the world.
Technological advancements:
There is a large under-addressed population of patients suffering from chronic wounds, especially in developing countries. Rise in per capita income of people in these countries has increased the rate of adoption of advanced wound care technologies. Better access to advanced wound care and increase in awareness about cost-effectiveness of advanced wound care therapies have led to a shift toward these solutions and products. Adoption of solutions and products such as negative pressure wound therapy (NPWT) and biologics, such as growth factors, skin grafts, and substitutes, has increased among healthcare providers. This is expected to drive the global diabetic ulcers treatment market. Advanced wound care is a rapidly expanding segment of the wound care market, and is attracting new players to introduce their products in the segment. Major players have been constantly innovating technologies and products, which have been instrumental in reducing the time of therapy, hospital stay, post-treatment complications, and redundancy of the disease. Advancements in NPWT therapy devices, new biologic products, constant innovation, and research in skin grafts and growth factors are expected to propel the global market.
Rise in awareness:
Growing incidences of diabetes due to changes in the food habits and lifestyle is mainly escalating the demand of the diabetic foot ulcer treatment market. Rise in the awareness towards the treatment procedures with the rise in the advertisements is additionally propelling the growth of the market. With significant rise in awareness about the catastrophic effects of untreated diabetic foot ulcers, the demand for efficient and highly effective wound healing treatments is witnessing considerable growth. Stakeholders in the diabetic foot ulcers treatment market are continually investing resources to develop new treatments leveraging advanced technologies. Furthermore, significant rise in the number of leg amputations due to diabetic foot ulcers has played a key role in accelerating research for new treatments.
New wound care devices:
Wound care is expected to remain the focal point of research and development activities related to diabetic foot ulcers treatment. With the common objective of reducing the number of amputations caused by diabetic foot ulcers, stakeholders in the current diabetic foot ulcers treatment market are currently working on developing new wound care devices.
For instance, Edixomed launched a new wound care device that utilizes the properties of nitric oxide to fasten the healing process of diabetic foot ulcers and minimize the number of leg amputations. The recently developed wound care system, the EDX110, healed diabetic foot ulcers at a faster rate in comparison with the traditionally used standard care dressings in the U.K. With the entry of similar innovative products in the diabetic foot ulcers treatment market, diabetic foot ulcers treatment are set to witness significant developments in coming years.
Restrains:
Lack of skilled persons in treating the ulcers due to diabetes effectively is quietly declining the growth of the market. Stringent rules and regulations by the government are also affecting the growth of the Diabetic Foot Ulcer Treatment Market. Lack of standardization is also one of the factors hampering the growth of the market.
Key benefits of the report:
- This study presents the analytical depiction of the global Diabetes ulcer treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Diabetes Ulcer treatment market share.
- The current market is quantitatively analyzed to highlight the global Diabetes Ulcer treatment market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global Diabetes Ulcer treatment market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Diabetes Ulcer treatment Market research report:
- What are the leading market players active in the Diabetes Ulcer treatment market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Diabetes Ulcer Treatment Market Report Highlights
| Aspects | Details |
 By Treatment Type |
|
 By Ulcer types |
|
 By End Users |
|
 By Region |
|
 Key Market Players | B. Braun Melsungen AG, Cardinal Health., Integra LifeSciences Corporation, Coloplast Corp, ConvaTec Group Plc, 3M, Mölnlycke Health Care AB, Tissue Regenix, Smith & Nephew |
Loading Table Of Content...
